Get started
Work

Donor-Lymphocyte Infusion Following Haploidentical Hematopoietic Cell Transplantation with Peripheral Blood Stem Cell Grafts and PTCy

Year: 2017
Type: article
Abstract: Background: Donor-lymphocyte infusion (DLI) as treatment for relapse following haploidentical hematopoietic cell transplantation (haploHCT) with post-transplant cyclophosphamide (PTCy) has been described in recipients of bone marrow grafts, but not recipients of T-cell replete, G-CSF mobilized peripheral blood (PB) grafts.
DOI: 10.1016/j.bbmt.2017.01.024
Authors: Scott R. Goldsmith, Michael Slade, John F. DiPersio, Peter Westervelt, Geoffrey L. Uy, Camille Abboud, Ravi Vij, Mark A. Schroeder, Todd Fehniger, Rizwan Romee
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2590954016
FWCI:
Cites:
Cited by: 1
Related to: 10